Head and Neck Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Head and Neck Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-12-10Clinical Trial Update: Prognostic Value of CTC in HNSCC Patients
This clinical trial update evaluates the prognostic value of circulating tumor cells in patients with Head and neck squamous cell carcinoma,…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck Cancer [Phase 2]
A Phase II study evaluating axitinib in patients with unresectable, recurrent, or metastatic head and neck squamous cell carcinoma has been …
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC) [Phase 2]
Phase 2 trial evaluating pralatrexate with vitamin B12 and folic acid for previously treated recurrent or metastatic head and neck squamous …
-
CLINICAL_TRIALS trial_result · 2015-09-01Clinical Trial Update: Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab [Phase 2]
This Phase II randomized trial assessed cetuximab with sorafenib versus cetuximab alone in metastatic head and neck squamous cell carcinomas…
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer [Phase 2]
Phase 2 study assessing tumor response to cetuximab in head and neck squamous cell carcinoma using FDG-PET/CT before and after treatment; re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-07-10Clinical Trial Update: A Study of PF-00299804 When Given Through a Feeding Tube in Locally Advanced Head and Neck Squamous Cell Carcinoma [NA]
This update reports the completion of a clinical trial evaluating PF-00299804 when administered via feeding tube in locally advanced head an…
-
CLINICAL_TRIALS trial_result · 2015-06-18Clinical Trial Update: Pilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of Head and Neck [EARLY_Phase 1]
This report documents the completion of a Phase 1 pilot trial evaluating the combination of raltegravir and cisplatin in head and neck squam…
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: Benefits of Exercise Training in Head and Neck Cancer Patients Undergoing Organ-Preserving Definitive Therapy [NA]
This ClinicalTrials.gov update notes the completed study evaluating the benefits of exercise training in patients with head and neck squamou…
-
CLINICAL_TRIALS trial_result · 2015-05-05Clinical Trial Update: Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer [Phase 2]
A Phase 2 trial update for cediranib maleate in patients with recurrent or metastatic head and neck squamous cell carcinoma has completed en…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer [Phase 2]
A Phase 2 trial evaluating lapatinib ditosylate in patients with metastatic or recurrent head and neck cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2015-04-14Clinical Trial Update: LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy [Phase 3]
Phase 3 trial comparing afatinib to methotrexate for recurrent/metastatic head and neck squamous cell carcinoma after platinum therapy; stud…
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: Study of Unilateral Neck Irradiation in Patients With SCC of the Head and Neck [NA]
This update notes the completion of a trial evaluating unilateral neck irradiation in patients with head and neck squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2015-03-27Clinical Trial Update: Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma [NA]
A completed clinical trial evaluating the biological effect of Tarceva (erlotinib) in patients with head and neck squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2015-03-26Clinical Trial Update: Pharmacogenetic Response to Chemotherapy Induction for ORL Cancers
A completed clinical trial evaluated pharmacogenetic responses to induction chemotherapy across head and neck squamous cell carcinomas of th…
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: Trial of OTD70DERM® in Radio-dermatitis Induced by Radiotherapy-Erbitux® [Phase 3]
Phase 3 clinical trial evaluating OTD70DERM for radiodermatitis caused by radiotherapy in head and neck cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Improving End of Life Care in Head and Neck Cancer
A Memorial Sloan Kettering trial evaluating end-of-life care for head and neck squamous cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck [Phase 3]
Phase 3 clinical trial update evaluating treatment for locally advanced head and neck squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
This Phase 2 study evaluated the Akt inhibitor MK-2206 in patients with recurrent or metastatic nasopharyngeal squamous cell carcinoma. The …
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Ponatinib for Squamous Cell Lung and Head and Neck Cancers [Phase 2, Phase 3]
Ponatinib was studied in Phase 2/Phase 3 trials for squamous cell carcinoma of the lung and head and neck squamous cell carcinoma. The studi…
-
CLINICAL_TRIALS trial_result · 2014-12-08Clinical Trial Update: Study of Sorafenib/Cetuximab in Head and Neck Cancer [Phase 1, Phase 2]
This document summarizes the completion of a Phase 1/2 clinical trial evaluating sorafenib in combination with cetuximab for head and neck s…
-
CLINICAL_TRIALS trial_result · 2014-11-24Clinical Trial Update: Cetuximab and Lenalidomide in Head and Neck [Phase 2]
Phase 2 trial update of cetuximab plus lenalidomide in head and neck squamous cell carcinoma. The study completed enrollment and results wer…
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers [Phase 3]
This is a Phase 3 trial evaluating REOLYSIN in combination with paclitaxel and carboplatin for platinum-refractory head and neck squamous ce…
-
CLINICAL_TRIALS trial_result · 2014-11-04Clinical Trial Update: Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck Carcinoma [Phase 2]
Phase 2 study of REOLYSIN in combination with paclitaxel and carboplatin for head and neck squamous cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-02Clinical Trial Update: Use of Pharmacogenetics to Select Erbitux or Cisplatin to Treat Head and Neck Cancer [NA]
This Georgetown University-sponsored trial evaluated pharmacogenetic-guided selection between cetuximab (Erbitux) and cisplatin for head and…
-
CLINICAL_TRIALS trial_result · 2014-09-30Clinical Trial Update: PF-00299804 in Patients With Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 trial of PF-00299804 in patients with metastatic or recurrent head and neck squamous cell carcinoma has completed.